Skip to content
TrustList
DA
Investor

Disruptive AI (venture capital)

An Israeli venture capital firm investing in artificial intelligence startups from early stage to growth

Disruptive AI (venture capital) cover

TrustList summary

Disruptive AI is a venture capital firm based in Israel that describes itself as the country's first fund focused specifically on artificial intelligence startups, investing from early stage through to growth. It says it works closely with founders, offering hands-on support alongside capital. Its portfolio has included a relationship-intelligence company for customer success teams that was acquired by Gainsight in 2024, a fraud-prevention platform for digital goods merchants, and Verbit, a transcription and captioning company combining artificial and human intelligence. Other portfolio companies span contract review, cybersecurity for smart contracts, and security questionnaire automation.

Summary written by TrustList from the business's own published information, Sep 2026.

Categories & features

Ask TrustList to introduce you to Disruptive AI (venture capital)

TrustList reads every request before passing it on, and sends it only where the funder's stage and focus look like a fit. We do not charge for introductions, and we cannot promise a reply.

Protected by reCAPTCHA - Google Privacy Policy and Terms apply.

Reviews

Write the first review of Disruptive AI (venture capital)

Used it? Your experience helps other buyers decide.

Write a review

Questions & answers

No questions yet. Be the first to ask about Disruptive AI (venture capital).

Disruptive AI (venture capital) alternatives

Similar listings buyers compare against this one.

Chicago-based accelerator for technology companies serving the real estate industry

Semiconductor and display equipment maker that also invests in startups through venture and research programmes

Medical device manufacturer making implants and therapies for heart, cancer and spinal conditions

Innovation platform running accelerator programmes and startup investments that link corporations with young technology companies

San Francisco early-stage technology venture firm led by two founding partners with a stated humane-technology outlook

Biotechnology investment arm of Access Industries backing private and public biopharma companies

Japanese property developer running office buildings, retail, hotels, airports and overseas real estate